Identity and percentage holding of significant shareholders
|Substantial holdings||Shares held||%|
|Global Health Investment Fund I, LLC||7,100,000||13.66%|
|Mr Hugh JJ Rylands||1,686,603||3.73%|
|Directors and related shareholders|
|Total Directors' holdings||1,060,362||2.04%|
|Total shares in issue||51,986,071||100.00%|
The date this data was updated: 26/06/2020
* - DATE OF LAST NOTIFICATION
** - Note 803,553 of these shares are held via a CFD/Spreadbet
genedrive shares are quoted and traded on the AIM market of the London Stock Exchange.
Authorised Share Capital: No authorised maximum number of shares are required. There are no shares held in treasury and there are no restrictions on transfer.
Issued Share Capital: The total number of genedrive plc ordinary shares of 1.5p each in issue is 51,986,701.
Number of AIM securities not in public hands is 12,829,644 or 24.7%.
16 June 2020
Investor Presentation June 2020
Thursday August 13, 2020
Saturday August 08, 2020
Tuesday August 04, 2020